Literature DB >> 34775574

The effect of 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase gene overexpression in the kynurenine pathway on the expression levels of indoleamine 2,3-dioxygenase 1 and interferon-γ in inflammatory conditions: an in vitro study.

Marzieh Rostaminejad1,2,3, Abdolmohamad Rostami4, Abbas Behzad-Behbahani2, Gholam Reza Rafiei Dehbidi2, Tahereh Kalantari5,6.   

Abstract

BACKGROUND: The kynurenine pathway (KP) can be involved in the pathogenesis of neurodegenerative diseases and excessive neurotoxic metabolite production. This study aimed to evaluate the effects of overexpression of murine 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (Acmsd) gene in inflammatory conditions in RAW 264.7 cell line to present more information about the effect of this gene on inflammatory conditions and the KP cycle. METHODS AND
RESULTS: The coding sequence of the Acmsd gene was cloned into pCMV6-AC-IRES-GFP expression vector with a green fluorescent protein (GFP) marker. To simulate inflammatory conditions, RAW 264.7 macrophage cells were stimulated by Lipopolysaccharide (LPS) 24 h before transfection, and transfected by Polyethyleneimine (PEI) with constructed plasmids expressing the Acmsd gene. The effect of Acmsd gene expression level on murine Interferon-gamma (Ifn-γ) and murine Indoleamine 2,3-dioxygenase 1 (Ido1) gene expression level was investigated by Real-Time PCR. According to the results of this study, good transfection efficiency was observed 72 h after transfection, and Acmsd expression level increased 29-fold (P < 0.001) in transfected LPS-stimulated cells compared to the control group (LPS-stimulated cells that were not transfected). Additionally, increased Acmsd expression level significantly down-regulated Ifn-γ (P < 0.001) and Ido1 (P < 0.01) expression level in transfected LPS-stimulated cells compared to LPS-stimulated cells.
CONCLUSIONS: Acmsd gene overexpression in inflammatory conditions can reduce the expression levels of the Ido1 gene, and its regulator, Ifn-γ. Consequently, it may be considered as a novel regulatory factor in the KP balance.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Acmsd; Ido1; Ifn-γ; Kynurenine pathway; Neurodegenerative diseases

Mesh:

Substances:

Year:  2021        PMID: 34775574     DOI: 10.1007/s11033-021-06935-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

1.  Monitoring of kynurenine pathway metabolites, neurotransmitters and their metabolites in blood plasma and brain tissue of individuals with latent toxoplasmosis.

Authors:  Jana Vondroušová; Miloš Mikoška; Kamila Syslová; Adéla Böhmová; Hana Tejkalová; Lukáš Vacek; Petr Kodym; Daniel Krsek; Jiří Horáček
Journal:  J Pharm Biomed Anal       Date:  2019-03-18       Impact factor: 3.935

Review 2.  Kynurenine pathway and human systems.

Authors:  Abdulla A-B Badawy
Journal:  Exp Gerontol       Date:  2019-11-05       Impact factor: 4.032

3.  [Gas chromatography analysis of essential oils. I].

Authors:  T M Malingré
Journal:  Pharm Weekbl       Date:  1968-09-06

Review 4.  The precision of gaze. A review.

Authors:  R M Steinman; W B Cushman; A J Martins
Journal:  Hum Neurobiol       Date:  1982

Review 5.  Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.

Authors:  Michael D Lovelace; Bianca Varney; Gayathri Sundaram; Matthew J Lennon; Chai K Lim; Kelly Jacobs; Gilles J Guillemin; Bruce J Brew
Journal:  Neuropharmacology       Date:  2016-03-16       Impact factor: 5.250

6.  Involvement of the kynurenine pathway in human glioma pathophysiology.

Authors:  Seray Adams; Charles Teo; Kerrie L McDonald; Anna Zinger; Sonia Bustamante; Chai K Lim; Gayathri Sundaram; Nady Braidy; Bruce J Brew; Gilles J Guillemin
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 7.  Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

Authors:  Andrew L Mellor; Henrique Lemos; Lei Huang
Journal:  Front Immunol       Date:  2017-10-27       Impact factor: 7.561

Review 8.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.

Authors:  Abdulla A-B Badawy
Journal:  Int J Tryptophan Res       Date:  2017-03-15

Review 9.  Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.

Authors:  Michael D Lovelace; Bianca Varney; Gayathri Sundaram; Nunzio F Franco; Mei Li Ng; Saparna Pai; Chai K Lim; Gilles J Guillemin; Bruce J Brew
Journal:  Front Immunol       Date:  2016-08-04       Impact factor: 7.561

10.  Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling.

Authors:  Yasuko Yamamoto; Wakana Yamasuge; Shinjiro Imai; Kazuo Kunisawa; Masato Hoshi; Hidetsugu Fujigaki; Akihiro Mouri; Toshitaka Nabeshima; Kuniaki Saito
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.